Related Experiment Video
Updated: Jun 12, 2026
09:24
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
Published on: April 15, 2014
[The immunogenicity of mouse neural stem cells]
Feng Gao1, Xiao-feng Yang, Xue-sheng Zheng
1Department of neurosurgery, Second Affiliated Hospital, Zhejiang University, Hangzhou, China. samgf@163.com
Summary
Mouse neural stem cells (NSCs) exhibit significantly lower immunogenicity compared to hepatocytes. This finding suggests NSCs may be a promising option for transplantation, potentially reducing immune rejection issues.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Context:
- Neural stem cell (NSC) transplantation holds therapeutic potential but faces challenges due to immune rejection.
- Understanding the immunogenicity of transplanted cells is crucial for successful clinical application.
Purpose:
- To investigate the immunogenicity of mouse neural stem cells (NSCs).
- To compare the immunogenicity of NSCs with that of hepatocytes.
- To assess the expression of MHC class I and II molecules on NSCs.
Summary:
- C57BL/6 mice were immunized with BALB/c NSCs or hepatocytes, followed by mixed lymphocyte culture to assess T-lymphocyte response.
- Flow cytometry revealed that approximately 87.55% of NSCs were negative for MHC class I and II, while only 27.45% of hepatocytes showed this profile.
- T-lymphocyte proliferation assays indicated a significantly lower immune response against NSCs compared to hepatocytes (P<0.01).
Impact:
- Mouse NSCs demonstrate considerably weaker immunogenicity than hepatocytes.
- These findings suggest that NSCs possess favorable immunogenic properties for transplantation therapies.
- Reduced immunogenicity of NSCs could mitigate immune rejection, paving the way for improved cell-based regenerative medicine strategies.
